Cramer's take on BMY | BMY Message Board Posts

Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  760 of 2896  at  10/22/2019 4:53:45 PM  by


The following message was updated on 10/22/2019 4:54:38 PM.

Cramer's take on BMY


Finally there's uber Cramer fave, Bristol-Myers (BMY) . For the longest time we have heard Merck's (MRK) Keytruda anti-cancer franchise beating that of Bristol-Myers. Today Bristol revealed that its Opdivo and Yervoy medicines, when taken together, met the end goal of extending the life of untreated lung cancer patients.

I think that this immunotherapy win is still one more reason to own the stock of Bristol-Myers which is buying Celgene (CELG) in what will be an incredible combination. And yet the company sells for less than 12 times earnings. I have been urging people to buy the stock of this company run so ably by Dr. Giovanni Caforio. I have been a broken record and I feel very lonely.

No matter, with its anti-cancer franchise so strong, and its management so brilliant, this stock can make you a lot more money than your index fund and still give you a 3% yield. You think there's a slowdown. Buy Bristol-Myers. You think there's no hope to the trade war? Buy Bristol-Myers. You think Brexit's going to wreak havoc on the world's economies. Buy Bristol-Myers. You think the Fed is going to hike or isn't going to hike, buy Bristol-Myers.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 17     Views: 360
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by